Neuroone Medical Technologies (NMTC) Change in Accured Expenses (2013 - 2026)
Neuroone Medical Technologies (NMTC) posted Change in Accured Expenses of $31133.0 for Q1 2026, up 105.03% on a QoQ basis from -$619376.0 in Q4 2025, and down 4.35% year-over-year from $32548.0 in Q1 2025.
Neuroone Medical Technologies (NMTC) Change in Accured Expenses (2013 - 2026) Analysis & Trends
Neuroone Medical Technologies' Change in Accured Expenses history runs 14 years deep, the most recent figure standing at $31133.0 for Q1 2026.
- Quarterly Change in Accured Expenses fell 4.35% year-over-year to $31133.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$211941.0 (down 3841.9% YoY) and the FY2025 annual result came in at -$54442.0, down 435.77% from the prior year.
- Change in Accured Expenses was $31133.0 for Q1 2026 at Neuroone Medical Technologies, up from -$619376.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $1.7 million in Q3 2022 and bottomed at -$1.4 million in Q1 2023.
- A 5-year average of -$5853.6 and a median of $73839.0 in 2025 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses soared 1227.97% — and 2023, when it sank 7447.94%.
- Neuroone Medical Technologies' Change in Accured Expenses stood at -$306125.0 in 2022, then sank by 69.4% to -$518584.0 in 2023, then advanced by 10.66% to -$463292.0 in 2024, then plunged by 33.69% to -$619376.0 in 2025, then soared by 105.03% to $31133.0 in 2026.
- Business Quant data shows NMTC's Change in Accured Expenses at $31133.0 in Q1 2026, -$619376.0 in Q4 2025, and $302463.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | 31,133.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31,133.00 |
| Mar 31, 2026 | 31,133.00 |
| Dec 31, 2025 | -619,376.00 |
| Dec 31, 2025 | -619,376.00 |
| Sep 30, 2025 | 302,463.00 |
| Sep 30, 2025 | 302,463.00 |
| Jun 30, 2025 | 73,839.00 |
| Jun 30, 2025 | 73,839.00 |
| Mar 31, 2025 | 32,548.00 |
| Mar 31, 2025 | 32,548.00 |
| Dec 31, 2024 | -463,292.00 |
| Dec 31, 2024 | -463,292.00 |
| Sep 30, 2024 | 236,795.00 |
| Sep 30, 2024 | 236,795.00 |
| Jun 30, 2024 | 199,613.00 |
| Jun 30, 2024 | 199,613.00 |
| Mar 31, 2024 | 98,390.00 |
| Mar 31, 2024 | 98,390.00 |
| Dec 31, 2023 | -518,584.00 |
| Dec 31, 2023 | -518,584.00 |